Croda International Plc has announced its acquisition of Enza Biotech AB, a research enterprise established as a spinout company from Lund University in Sweden.
Enza Biotech was founded in 2012 by researchers at Lund University with the aim to develop the next generation of renewable surfactants using carbohydrate-based chemistry. Through this acquisition, Enza Biotech’s patented technology will enhance Croda’s wellestablished natural and renewable product portfolio to offer their customers, particularly in the personal care, crop care and health care markets, the sustainable ingredients they are looking for to satisfy the demands of consumers.
Croda will also gain the expertise of Enza co-founders Maria Andersson and Stefan Ulvenlund, and their team, as they become full time employees to lead the commercialisation of their work using Croda’s technical and formulation expertise, global operational footprint and sales force and track record at bringing new technologies to market.
